79 related articles for article (PubMed ID: 21188322)
1. Further insights into the causes of thrombocytopenia in chronic hepatitis C.
Giannini EG; Savarino V
J Gastrointestin Liver Dis; 2010 Dec; 19(4):357-8. PubMed ID: 21188322
[No Abstract] [Full Text] [Related]
2. Thrombocytopenia in chronic hepatitis C.
Olariu M; Olariu C; Olteanu D
J Gastrointestin Liver Dis; 2010 Dec; 19(4):381-5. PubMed ID: 21188328
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of HCV treatment: who does well and who does not?
Hsu CS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
[No Abstract] [Full Text] [Related]
4. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
5. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
7. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.
Fanning L; Kenny E; Sheehan M; Cannon B; Whelton M; O'Connell J; Collins JK; Shanahan F
Hepatology; 1999 Mar; 29(3):904-7. PubMed ID: 10051496
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.
Schmidt WN; Stapleton JT; LaBrecque DR; Mitros FA; Kirby PA; Phillips MJ; Brashear DL
Hepatology; 2000 Mar; 31(3):737-44. PubMed ID: 10706566
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune thrombocytopenia in chronic liver disease].
Panasiuk A; Zak J
Pol Merkur Lekarski; 2001 Dec; 11(66):487-90. PubMed ID: 11899844
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection acquired in childhood.
Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in patients with chronic hepatitis C: a possible role of HCV on platelet progenitor cell maturation.
El Barbary MA; Saad AE; Attia FM; Mandour MI; Haidara MA; Dallak MM; Isenovic ER
Angiology; 2010 Apr; 61(3):304-13. PubMed ID: 19689996
[TBL] [Abstract][Full Text] [Related]
15. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
[TBL] [Abstract][Full Text] [Related]
16. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
17. Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.
Antonelli G; Riva E; Maggi F; Vatteroni ML; Simeoni E
J Infect Dis; 1999 Oct; 180(4):1411-2. PubMed ID: 10479188
[No Abstract] [Full Text] [Related]
18. [Influence factors and predictors in anti-viral therapy for chronic hepatitis C].
Jin S; Zhou WP; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):124-5. PubMed ID: 14980130
[No Abstract] [Full Text] [Related]
19. Value of AST/ALT ratio as fibrotic predictor in chronic hepatitis C.
Park G; Jones DB; Katelaris P
Am J Gastroenterol; 2005 Jul; 100(7):1623-4; author reply 1624. PubMed ID: 15984996
[No Abstract] [Full Text] [Related]
20. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
